SCHEMBL4595206

SCHEMBL4595206

NC(Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 5/20 0.44
▸ DPP8 Q6V1X1 3/20 0.44
▸ DPP9 Q86TI2 3/20 0.44
▸ ACE P12821 8/20 0.43
▸ REN P00797 3/20 0.42
▸ LTA4H P09960 3/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ F2 P00734 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ PEPD P12955 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ PTGS1 P23219 1/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ PTGS2 P35354 1/20 0.42
▸ HRH1 P35367 1/20 0.42
▸ THPO P40225 1/20 0.42
▸ PMP22 Q01453 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ ACE2 Q9BYF1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4595209 1.00 DPP4 (0.44) DPP4DPP8DPP9ACEREN
SCHEMBL5734357 1.00 DPP4 (0.44) DPP4DPP8DPP9ACEREN
SCHEMBL10454953 0.96 TRHR (0.43) DPP4DPP8DPP9ACEREN
SCHEMBL10454951 0.96 TRHR (0.43) DPP4DPP8DPP9ACEREN
SCHEMBL7759091 0.96 DPP4 (0.42) DPP4DPP8DPP9ACEREN
SCHEMBL7759104 0.96 DPP4 (0.42) DPP4DPP8DPP9ACEREN
SCHEMBL678488 0.93 DPP4 (0.42) DPP4DPP8DPP9ACEREN
SCHEMBL678487 0.93 DPP4 (0.42) DPP4DPP8DPP9ACEREN
SCHEMBL29591738 0.91 TRHR (0.46) —
SCHEMBL29630592 0.91 TRHR (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-85105655-A Process for preparing novel derivatives of 1-methyl-4, 5-dihydroorotic acid and pharmaceutical compositions thereof — 1987-01-28 — — CN claimed
US-20230358751-A1 METHODS FOR THE DETECTION AND TREATMENT OF PROSTATE CANCER BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2023-11-09 — — US disclosed
CN-101951935-A Therapeutic agent for cerebral ischemic disorder OTSUKA PHARMA CO LTD 2011-01-19 — — CN disclosed
CN-101309682-A Modulation of neurogenesis by pde inhibition BRAINCELLS INC (US) 2008-11-19 — — CN disclosed
EP-1442741-B1 Compositions and methods for treating obesity US DEPT OF VETERANS AFFAIRES A (US) 2008-01-16 — — EP disclosed
US-7144865-B2 Compositions and methods for treating obesity THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) 2006-12-05 — — US disclosed
US-20040185125-A1 Compositions and methods for treating obesity UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS 2004-09-23 — — US disclosed
EP-1442741-A1 Compositions and methods for treating obesity Moon, K. Song (US) 2004-08-04 — — EP disclosed
Send feedback